reviewTop 1% cited
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Gynecologic Oncology · 2008 · Vol. 112(1) · pp. 265–274
Robert E. Bristow✉(Johns Hopkins University)Isha Puri(Johns Hopkins University)S. Dennis(Memorial Sloan Kettering Cancer Center)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometrial and Cervical Cancer TreatmentsMedicineCytoreductive surgerySurgeryCohortOvarian cancerCancerPrognostic variableCohort studyInternal medicineOverall survival
MeSH terms
FemaleHumansNeoplasm Recurrence, LocalOvarian NeoplasmsGynecologic Surgical Procedures
Funding
- Foundation for Women's Cancer
- Entertainment Industry Foundation
Citations
369
FWCI
24.64
field-weighted impact
References
75
Percentile
100%
vs. same field & year
Citations per year
Cited by
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2013 · 1,110 citations
References
Analysis of Incomplete Multivariate Data
Technometrics · 2000 · 5,644 citations
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
Gynecologic Oncology · 1992 · 553 citations
Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
Gynecologic Oncology · 1998 · 515 citations
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Gynecologic Oncology · 2006 · 398 citations
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Annals of Surgical Oncology · 2006 · 418 citations
Cancer Statistics, 2008
CA A Cancer Journal for Clinicians · 2008 · 10,197 citations
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
Gynecologic Oncology · 2004 · 431 citations
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
American Journal of Obstetrics and Gynecology · 1994 · 670 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.